Suppr超能文献

参与者对临床试验中知情同意的理解:系统评价和更新的荟萃分析。

Participants' understanding of informed consent in clinical trials: A systematic review and updated meta-analysis.

机构信息

Department of Molecular Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.

Beijing Jishuitan Hospital, Capital Medical University, Beijing Research Institute of Traumatology and Orthopaedics, Beijing, China.

出版信息

PLoS One. 2024 Jan 2;19(1):e0295784. doi: 10.1371/journal.pone.0295784. eCollection 2024.

Abstract

Obtaining written informed consent from participants before enrolment in a study is essential. A previous study showed that only 50% of the participants in clinical trials understood the components of informed consent, and the methods of participants' understanding of informed consent were controversial. This updated meta-analysis aimed to estimate the proportion of participants in clinical trials who understand the different informed consent components. PubMed, EMBASE, the Cochrane Library, and Scopus were searched till April 2023. Therapeutic misconception, ability to name one risk, knowing that treatments were being compared, and understanding the nature of the study, the purpose of the study, the risks and side-effects, the direct benefits, placebo, randomization, voluntariness, freedom to withdraw, the availability of alternative treatment if withdrawn from the trial, confidentiality, compensation, or comprehension were evaluated. This meta-analysis included 117 studies (155 datasets; 22,118 participants). The understanding of the risks and side-effects was investigated in the largest number of studies (n = 100), whereas comparehension was investigated in the smallest number (n = 11). The highest proportions were 97.5%(95% confidence interval (CI): 97.1-97.9) for confidentiality, 95.9% (95% confidence interval (CI): 95.4-96.4) for compensation, 91.4% (95% CI: 90.7-92.1) for the nature of study, 68.1% (95% CI: 51.6-84.6) for knowing that treatments were being compared, and 67.3% (95% CI: 56.6-78) for voluntary nature of participants. The smallest proportions were the concept of placebo (4.8%, 95%CI: 4.4-5.2) and randomization(39.4%, 95%CI: 38.3-40.4). Our findings suggested that most participants understood the fundamental components of informed consent (study confidentiality, nature, compensation, voluntariness, and freedom to withdraw). The understanding of other components, such as placebo and randomization was less satisfactory.

摘要

在研究招募参与者之前,获得参与者的书面知情同意至关重要。先前的研究表明,临床试验中只有 50%的参与者理解知情同意书的组成部分,并且参与者理解知情同意书的方法存在争议。这项更新的荟萃分析旨在估计临床试验中理解不同知情同意书组成部分的参与者比例。我们检索了 PubMed、EMBASE、Cochrane 图书馆和 Scopus,检索时间截至 2023 年 4 月。我们评估了治疗误解、能够说出一个风险、知道正在比较治疗方法、理解研究的性质、研究的目的、风险和副作用、直接益处、安慰剂、随机化、自愿性、自由退出、如果退出试验可获得替代治疗、保密性、补偿或理解。这项荟萃分析包括 117 项研究(155 个数据集;22118 名参与者)。研究最多评估了风险和副作用的理解情况(n=100),而最少评估了理解情况(n=11)。最高的比例是保密性 97.5%(95%置信区间(CI):97.1-97.9)、补偿 95.9%(95%CI:95.4-96.4)、研究性质 91.4%(95%CI:90.7-92.1)、知道正在比较治疗方法 68.1%(95%CI:51.6-84.6)和参与者的自愿性质 67.3%(95%CI:56.6-78)。比例最小的是安慰剂的概念(4.8%,95%CI:4.4-5.2)和随机化(39.4%,95%CI:38.3-40.4)。我们的研究结果表明,大多数参与者理解知情同意书的基本组成部分(研究保密性、性质、补偿、自愿性和自由退出)。对其他组成部分(如安慰剂和随机化)的理解则不太令人满意。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/10760836/a741c934783c/pone.0295784.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验